VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CAHCardinal Health, Inc.
$279.25$65.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCAHCash Flow

Cardinal Health, Inc. (CAH) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow of $1.4B and free cash flow of $1.2B in the latest quarter were heavily influenced by a $462M working capital inflow, with buybacks of $500M and dividends of $126M exceeding the underlying free cash generation in several periods.

Income StatementBalance SheetCash FlowRatios

CAH Cash Flow Statement

Annual statement

CAH Cash Flow Statement

Cardinal Health, Inc. (CAH) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Cash from Operations5.6B5.17B2.4B3.76B2.84B3.12B2.43B1.96B2.72B2.77B1.18B2.97B2.54B2.52B1.73B1.18B1.39B2.13B1.57B1.51B1.22B2.14B2.85B2.62B1.4B983.9M871.7M638.2M345.7M143.1M39.2M
Operating CF Margin %-2.04%1.08%1.66%1.39%1.72%1.5%1.28%1.87%2.02%0.91%2.44%2.48%2.77%1.71%1.09%1.36%2.17%1.63%1.73%1.41%2.69%3.92%4.07%2.46%1.92%1.82%1.66%1.38%0.68%0.21%
Operating CF Growth %288.48%115.85%-36.28%32.28%-8.9%28.53%23.93%-27.99%-1.66%133.78%-60.15%16.97%0.63%46.15%46.85%-15.67%-34.65%36.16%3.65%23.63%-42.85%-24.91%8.59%87.75%42.09%12.87%36.59%84.61%141.58%265.05%-67.92%
Net Income1.82B1.71B1.57B853M331M-933M612M-3.69B1.36B259M1.29B1.43B1.21B1.16B335M1.07B966M587M758.2M847.2M1.93B1B1.05B1.52B1.38B1.14B857.4M717.8M481M448.5M334.8M
Depreciation & Amortization970M956M790M710M692M692M783M913M1B1.03B717M641M451M459M397M325M313.3M254.4M399.4M381.3M322.1M392.7M409.7M299.2M265.8M243.5M280.6M245.9M233.5M64.3M51.3M
Stock-Based Compensation383M367M244M121M96M089M90M82M85M96M111M110M96M93M85M79.5M99.5M122.8M122.3M138.1M237.3M000000000
Deferred Taxes91M91M243M-104M-40M7M496M-961M-83M-1.01B291M87M219M26M21M158M128M120M69.5M26.9M11.7M-5.7M54.7M102.8M215.2M239.7M149.1M128.5M132.4M90.1M32.9M
Other Non-Cash Items-27M-31M74M672M1.31B2.23B160M-450M-397M1.5B53M78M96M25M890M-28M-46M198M617.9M461.2M-605.5M671.8M455.6M-19M22.2M42.6M41.4M37.5M29.7M23.4M8.6M
Working Capital Changes2.38B2.09B-523M1.51B457M1.12B289M6.06B755M907M-1.27B623M452M755M-9M-434M-46M875M-357.4M-121.5M-436.3M157M999.1M733.2M-486.4M-682.7M-456.8M-636.8M-503.7M-208.4M-96.4M
Change in Receivables-603M-408M-833M-996M-950M-1.53B-904M82M-751M-871M-665M-866M-870M925M216M-129M-457M21M-713.6M-296.1M-783.1M-895.3M-15.9M-411.7M-413.7M142.7M-31.4M-377.3M-214.5M-211.7M-15.3M
Change in Inventory-923M-488M-1.82B1.11B-412M-1.07B-1.58B-409M-551M-1.21B-673M-1.18B-779M142M-370M-495M-665M477M-431.2M634.3M217.4M-356.1M71.6M237.5M-217.9M-1.07B-1.52B-1.07B-317.9M-474.3M-106.6M
Change in Payables3.97B3.46B2.73B1.82B2.82B3.43B2.33B-162M1.86B2.57B564M2.81B1.95B-196M426M319M1.36B451M768.1M-848.2M00000000000
Cash from Investing-2.69B-2.58B-5.61B-1.85B-454M567M-378M493M338M-5.61B-405M-4.08B-849M-850M-2.38B-377M-2.03B127.1M-542.9M-726.4M1.54B-1.19B-877.4M-2.44B-343.7M-650.9M-633.4M-287.3M-409.6M-112.2M-17.9M
Capital Expenditures-698M-649M-547M-511M-481M-387M-400M-375M-328M-384M-387M-465M-300M-249M-195M-263M-291.3M-255.8M-533.4M-376.1M-357.4M-443.2M-571.7M-410.2M-423.2M-285.4M-341.2M-307.8M-467.4M-114.7M-75.2M
CapEx % of Revenue0.27%0.26%0.25%0.23%0.23%0.21%0.25%0.25%0.23%0.28%0.3%0.38%0.29%0.27%0.19%0.24%0.28%0.26%0.56%0.43%0.41%0.56%0.79%0.64%0.75%0.56%0.71%0.8%1.86%0.54%0.41%
Acquisitions-2.1B-1.99B-5.25B-1.19B-10M901M-3M0-82M-6.14B-132M-3.61B-503M-519M-2.24B-174M-2.3B-32M-128.6M-4.7M-1.63B-362.2M-273.2M-2.09B-26.8M-383.8M-364.3M-69.6M-147.5M-45.8M0
Investments-------------------------------
Other Investing34M15M-10M18M8M31M02M763M862M3M13M53M0003M148M-6M-697.9M3.16B-86.6M-163.2M48.7M106.3M18.3M72.1M60.2M57.9M6.1M23.5M
Cash from Financing-2.23B-1.6B1.95B-847M-3.05B-2.46B-1.32B-2.2B-2.29B-2.28B3.75B-1.14B60M-710M275M-454M-192.6M-727.5M-468.2M-803.2M-2.64B-1.03B-1.66B-815.7M-712.3M114.9M108.7M-31.7M-141.8M31M-82.5M
Debt Issued (Net)-151M337M3.22B356M-579M-885M-570M-1.4B-1.1B-1B4.86B20M1.44B112M980M258M312M-1.49B-304.2M296.4M630.5M299.8M-1.21B512.8M326.9M333M32.6M372.7M-102.2M-26.9M-368.5M
Equity Issued (Net)-1.48B-1.36B-765M-750M-2B-1B-200M-350M-600M-550M-600M-651M-1.04B-673M-329M-408M-207M-190M39.2M-953.7M-3.11B-1.26B-389.8M-1.28B-994.4M-168.3M112.7M-243.9M14.3M-95.8M70.5M
Dividends Paid-488M-491M-494M-499M-525M-559M-573M-569M-577M-581M-577M-512M-460M-415M-353M-300M-274.2M-253.1M-200.4M-173.1M-144.4M-101.8M-51.7M-52.3M-44.8M-45M-36.6M-28M-56.7M-11.5M-9.1M
Share Repurchases-1.48B-1.36B-765M-750M-2B-1B-200M-350M-600M-550M-600M-651M-1.04B-673M-450M-450M-270M-230M0-1.18B-3.66B-1.5B-500.3M-1.5B-1.19B-308.3M-139.4M-341.4M-47.8M-155M-37.7M
Other Financing-112M-90M-13M46M53M-19M26M120M-14M-144M59M4M117M266M-23M-4M-23.4M1.2B-2.8M27.2M-15.5M28.9M-6.9M7.1M0-4.8M0-130.5M-19M-40.8M-41.7M
Net Change in Cash671M982M-1.26B1.06B-669M1.31B636M240M768M-5.12B4.52B-2.26B1.75B964M-373M345M-826M1.53B556.2M-17.5M121.5M-79.1M315.7M-628M342M447.9M347M319.2M-208.1M61.9M-61.2M
Free Cash Flow4.9B4.53B1.85B3.25B2.36B2.73B2.03B1.58B2.39B2.38B797M2.51B2.24B2.27B1.53B913M1.1B1.88B1.03B1.14B865.7M1.7B2.28B2.21B974.8M698.5M530.5M330.4M-121.7M28.4M-36M
FCF Margin %1.9%1.78%0.83%1.43%1.15%1.51%1.25%1.04%1.65%1.74%0.61%2.06%2.18%2.5%1.52%0.85%1.07%1.91%1.08%1.3%1%2.13%3.14%3.43%1.72%1.37%1.11%0.86%-0.48%0.13%-0.2%
FCF Growth %10.09%144.59%-43.09%37.58%-13.6%34.8%28.01%-33.79%0.42%199.12%-68.2%11.88%-1.54%48.5%67.8%-17.25%-41.26%81.67%-8.99%31.22%-48.99%-25.52%2.89%127.17%39.56%31.67%60.56%371.49%-528.52%178.89%-173.32%
FCF per Share21.0319.097.6413.169.029.806.905.417.957.572.497.596.696.594.452.623.135.202.863.122.143.965.235.152.151.541.140.73-0.280.07-0.15
FCF Conversion (FCF/Net Income)2.70x3.02x1.54x4.42x8.62x-3.33x3.98x-0.53x2.00x10.81x0.92x2.08x2.09x2.16x5.17x1.10x1.45x3.32x1.36x1.16x0.63x2.14x2.71x1.78x0.99x0.93x1.02x0.94x0.76x0.58x0.22x
Interest Paid406M406M315M214M203M0182M226M285M320M200M174M150M152M128M118M116M158M201.8M239.8M00000000000
Taxes Paid338M338M444M191M156M0273M368M311M425M686M635M529M632M899M513M588M514M429.3M116M00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Working capital reversal volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2027Q1)

Operating Cash Flow Swings Dwarf Earnings

As reported in the quarterly cash flow data, CAH's operating cash flow ranged from negative $1.6B to positive $2.9B across the ten quarters, while net income stayed between roughly $236M and $554M, an unusually wide gap that signals earnings quality is driven largely by working capital timing.

The OCF-to-net-income ratio swung from negative values to above 8x, which indicates that reported profit is a poor proxy for cash generation in any single quarter. This pattern suggests the operating cash line is dominated by receivables, payables, and inventory movements rather than by sustainable earnings power. Investors should monitor whether the multi-quarter average conversion stabilizes near 1x-2x, which would support the earnings base, or whether the large swings continue to obscure underlying profitability.

Working Capital Drives Cash Volatility

According to the reported figures, working capital changes ranged from a $2.3B outflow to a $2.2B inflow in the ten quarters, making working capital the dominant variable in CAH's quarterly operating cash flow and far larger than the underlying net income base.

The alternating inflows and outflows suggest that collection timing, inventory build, and supplier payment cycles are materially affecting reported operating cash flow. Given the distribution model's structurally thin margins, even modest timing shifts can produce outsized cash swings. The pattern warrants further investigation into whether the sizable recent inflows reflect durable payables management or temporary timing benefits that may reverse.

Free Cash Flow Margins Remain Thin but Positive

Based on reported figures, CAH's free cash flow margin ranged from negative 3.3% to 5.1% across the ten quarters, with the most recent quarter at 1.8%, indicating that free cash generation is real but highly variable relative to a revenue base exceeding $60B per quarter.

Capital expenditures remain very small relative to revenue, at roughly 0.2% to 0.4% of sales, so FCF variability is almost entirely a function of operating cash flow rather than investment intensity. The recent FCF margin of about 1.8% is a modest figure that appears to reflect a normalization after the strong late-2025 inflows. Investors should treat the trailing trajectory as directionally positive but not yet demonstrating a stable run-rate.

Shareholder Returns Exceed Free Cash Generation

As reported in the financial statements, CAH paid roughly $120M to $130M in dividends each quarter and executed buybacks ranging from $15M to $765M, with several periods where combined shareholder distributions appear to exceed the free cash flow generated in that same period.

The consistent dividend suggests a stable distribution policy, while the lumpy buyback activity appears to track the timing of strong operating cash inflows rather than a fixed programme. Acquisition outflows, including a roughly $2.8B net outflow in one quarter, indicate that M&A has absorbed significant capital in recent periods. Investors should monitor whether repurchases and acquisitions continue to be funded from working capital releases, which could prove unsustainable if those inflows reverse.

Thin Cash Margins Leave Little Buffer

As reported in the quarterly figures, CAH's cash conversion looks strong in several quarters only because of working capital releases, and a reversal of those timing benefits could expose a much weaker underlying cash base than the headline inflows imply.

Several of the largest operating cash inflows coincide with working capital inflows of $1B to $2B, which suggests that headline cash generation may overstate the recurring earnings power of a business with roughly 0.7% net margins. Stock-based compensation and acquisition-related outflows also shape reported cash lines, so the cash flow statement may not fully reveal the economics of the distribution model. Investors should treat periods of unusually high operating cash flow with caution until conversion stabilizes across a full cycle.

CAH — Frequently Asked Questions

Quick answers to the most common questions about buying CAH stock.

How much cash does Cardinal Health, Inc. (CAH) generate from operations?

Cardinal Health, Inc. (CAH) generated $5.17B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Cardinal Health, Inc.'s free cash flow?

Cardinal Health, Inc. (CAH) generated $4.53B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cardinal Health, Inc.'s capital expenditure (CapEx)?

Cardinal Health, Inc. (CAH) spent $649.0M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cardinal Health, Inc. distribute cash to shareholders?

In 2026, Cardinal Health, Inc. (CAH) returned $491.0M to shareholders via cash dividends and spent $1.36B on share repurchases. This shows the company's commitment to returning capital to its equity investors.